Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiichi Ishiwata

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Current Medicinal Chemistry|August 22, 2006
PET tracers for imaging of the dopaminergic systemPhilip H Elsinga, Kentaro Hatano, Kiichi Ishiwata
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 11, 2015
Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loadingKenji Ishibashi, Keiichi Kawasaki, Kiichi Ishiwata, et al.
Human Brain Mapping|April 11, 2016
Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loadingKenji Ishibashi, Kei Wagatsuma, Kiichi Ishiwata, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|February 11, 2003
[Three-dimensional projection display of striatum dopamine function measured by PET]Keiichi Oda, Kenji Ishii, Yuichi Kimura, et al.
Synapse (New York, N.Y.)|February 14, 2002
Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography techniqueToru Sasaki, Kiichi Ishiwata, Tetsuhito Murata, et al.
Journal of the Neurological Sciences|January 28, 2014
Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effectKenji Ishibashi, Keiichi Oda, Kiichi Ishiwata, et al.
Synapse (New York, N.Y.)|March 6, 2003
Different brain kinetics of two sigma 1 receptor ligands, [3H](+)-pentazocine and [11C]SA4503, by P-glycoprotein modulationKazunori Kawamura, Tadayuki Kobayashi, Kiyoshi Matsuno, et al.
Nuclear Medicine and Biology|May 28, 2003
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligandsKiichi Ishiwata, Kazunori Kawamura, Tadayuki Kobayashi, et al.
BMC Research Notes|October 1, 2015
Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case reportKenji Ishibashi, Hirofumi Nishina, Kiichi Ishiwata, et al.
Nuclear Medicine and Biology|July 10, 2012
Application of [¹¹C]SA4503 to selection of novel σ₁ selective agonistsJun Toyohara, Tadayuki Kobayashi, Shiro Mita, et al.
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Current Medicinal Chemistry|August 22, 2006
PET tracers for imaging of the dopaminergic systemPhilip H Elsinga, Kentaro Hatano, Kiichi Ishiwata
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 11, 2015
Reduced uptake of 18F-FDG and 15O-H2O in Alzheimer's disease-related regions after glucose loadingKenji Ishibashi, Keiichi Kawasaki, Kiichi Ishiwata, et al.
Human Brain Mapping|April 11, 2016
Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loadingKenji Ishibashi, Kei Wagatsuma, Kiichi Ishiwata, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|February 11, 2003
[Three-dimensional projection display of striatum dopamine function measured by PET]Keiichi Oda, Kenji Ishii, Yuichi Kimura, et al.
Synapse (New York, N.Y.)|February 14, 2002
Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography techniqueToru Sasaki, Kiichi Ishiwata, Tetsuhito Murata, et al.
Journal of the Neurological Sciences|January 28, 2014
Comparison of dopamine transporter decline in a patient with Parkinson's disease and normal aging effectKenji Ishibashi, Keiichi Oda, Kiichi Ishiwata, et al.
Synapse (New York, N.Y.)|March 6, 2003
Different brain kinetics of two sigma 1 receptor ligands, [3H](+)-pentazocine and [11C]SA4503, by P-glycoprotein modulationKazunori Kawamura, Tadayuki Kobayashi, Kiyoshi Matsuno, et al.
Nuclear Medicine and Biology|May 28, 2003
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligandsKiichi Ishiwata, Kazunori Kawamura, Tadayuki Kobayashi, et al.
BMC Research Notes|October 1, 2015
Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case reportKenji Ishibashi, Hirofumi Nishina, Kiichi Ishiwata, et al.
Nuclear Medicine and Biology|July 10, 2012
Application of [¹¹C]SA4503 to selection of novel σ₁ selective agonistsJun Toyohara, Tadayuki Kobayashi, Shiro Mita, et al.
Pageof 21